5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with ci 1020 in 1 studies
| Studies (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Trials (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Recent Studies (post-2010) (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Studies (ci 1020) | Trials (ci 1020) | Recent Studies (post-2010) (ci 1020) |
|---|---|---|---|---|---|
| 73 | 0 | 8 | 7 | 0 | 1 |
| Protein | Taxonomy | 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide (IC50) | ci 1020 (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Homo sapiens (human) | 0.492 | |
| Endothelin-1 receptor | Homo sapiens (human) | 0.0006 | |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | 0.0004 | |
| Endothelin receptor type B | Mus musculus (house mouse) | 0.78 | |
| Endothelin-1 receptor | Mus musculus (house mouse) | 0.0003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bal, R; Boyd, SA; Chiou, WJ; Dixon, DB; Hernandez, L; Jae, HS; Kester, JA; Mantei, RA; Marsh, KC; Novosad, EI; Opgenorth, TJ; Sorensen, BK; Tasker, AS; von Geldern, TW; Winn, M; Wu-Wong, JR | 1 |
1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and ci 1020
| Article | Year |
|---|---|
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.
Topics: Animals; Aorta; Atrasentan; Biological Availability; Endothelin Receptor Antagonists; Endothelins; Hydrolysis; Male; Molecular Structure; Phosphatidylinositols; Pyrrolidines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Structure-Activity Relationship; Vasoconstriction | 1996 |